These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. TNFalpha therapy in psoriatic arthritis and psoriasis. Mease P Ann Rheum Dis; 2004 Jul; 63(7):755-8. PubMed ID: 15194567 [No Abstract] [Full Text] [Related]
3. Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis. Girolomoni G; Altomare G; Ayala F; Berardesca E; Calzavara-Pinton P; Chimenti S; Peserico A; Puglisi Guerra A; Vena GA Immunopharmacol Immunotoxicol; 2012 Aug; 34(4):548-60. PubMed ID: 22296031 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study. Esposito M; Giunta A; Mazzotta A; Zangrilli A; Babino G; Bavetta M; Perricone R; Chimenti S; Chimenti MS Dermatology; 2012; 225(4):312-9. PubMed ID: 23295383 [TBL] [Abstract][Full Text] [Related]
5. Detection of antibodies to anti-TNF agents in psoriatic patients: a preliminary study. Cozzani E; Burlando M; Parodi A G Ital Dermatol Venereol; 2013 Apr; 148(2):171-4. PubMed ID: 23588142 [TBL] [Abstract][Full Text] [Related]
6. Adverse reactions during biological drug therapy in psoriasis:clinical series and a review of the literature. Montesu MA; Addis GM; Satta R; Cottoni F G Ital Dermatol Venereol; 2011 Aug; 146(4):273-81. PubMed ID: 21785393 [TBL] [Abstract][Full Text] [Related]
7. [Biological treatment of psoriasis and psoriatic arthritis]. Kragballe K; Deleuran B Ugeskr Laeger; 2008 Jun; 170(24):2148-50. PubMed ID: 18565300 [TBL] [Abstract][Full Text] [Related]
8. Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review. Brezinski EA; Follansbee MR; Armstrong EJ; Armstrong AW Curr Pharm Des; 2014; 20(4):513-28. PubMed ID: 23565632 [TBL] [Abstract][Full Text] [Related]
10. Matching-adjusted indirect comparison of adalimumab vs etanercept and infliximab for the treatment of psoriatic arthritis. Kirson NY; Rao S; Birnbaum HG; Kantor E; Wei RS; Cifaldi M J Med Econ; 2013; 16(4):479-89. PubMed ID: 23339434 [TBL] [Abstract][Full Text] [Related]
12. Switching tumour necrosis factor alpha antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year period. Conti F; Ceccarelli F; Marocchi E; Magrini L; Spinelli FR; Spadaro A; Scrivo R; Valesini G Ann Rheum Dis; 2007 Oct; 66(10):1393-7. PubMed ID: 17613555 [TBL] [Abstract][Full Text] [Related]
13. [Cutaneous pseudolymphoma with two types of anti-TNFα: a class effect?]. Schmutz JL; Trechot P Ann Dermatol Venereol; 2012 Oct; 139(10):695-6. PubMed ID: 23122389 [No Abstract] [Full Text] [Related]
14. Combination biologic treatment of refractory psoriasis and psoriatic arthritis. Cuchacovich R; Garcia-Valladares I; Espinoza LR J Rheumatol; 2012 Jan; 39(1):187-93. PubMed ID: 22210681 [No Abstract] [Full Text] [Related]